– The SET Index on Friday (March 12) stumbled after the Government decided to delay AstraZeneca’s vaccine rollout over blood clot concerns, analysts looked at this issue as a negative sentiment towards the index in the short-term. However, having hopes for further Covid-19 restrictions easing as it will be discussed at the CCSA’s meeting on March 19.
Analysts maintain healthcare-tourism play as an investment theme, recommending AOT, BDMS and CHG, while picking JMART as a red-hot stock. In addition, analysts expect the SET to move within the range 1,550-1,560 points this week.
– TMB announced an early retirement programme with a maximum compensation of 17 months, as part of the integration between the bank and Thanachart.
– JR expected the revenue and earnings to grow by leaps and bounds this year and planned to bid for Yellow and Pink Line phase 2 to strengthen the backlog to more than 10 billion baht, showing a solid financial position from the increased capital of billions baht.
– BCH rejoiced as its subsidiary company has been licensed for importing Covid-19 vaccine, meanwhile expecting an excellent performance in 2021, supported by affiliated hospitals and country reopening from Oct 1 onwards. Also, BCH aimed to open the medical cannabis clinics.
– BGRIM targeted an additional 1,000MW this year as M&A deals in Thailand, Malaysia and Vietnam with a combined 2,500-3,600MW are expected to be completed in the second half of 2021, confirming the EBITDA to exceed 30% after signing a new PPA and gas prices decrease.
– “Pradej” to proceed the restructuring of “Wind Energy”’s shareholding structure , beginning with “Share Swap”.